A new registered nurse is working on a pediatric unit in a large teaching hospital that uses focus charting with the acronym DAR. What will the nurse be charting?
a. Data, assessment, reaction
b. Data, assessment, recommendation
c. Data, actions, response
d. Data, actions, recovery
C
Each entry includes data, actions, and patient response (DAR) for the particular patient situation. Focus charting (DAR) is a unique narrative format in that it places less emphasis on patient problems and instead focuses on patient concerns such as a sign or symptom, a condition, a behavior, or a significant event. There are no reaction, recommendation, recovery, or assessment in DAR.
You might also like to view...
An Army nurse is preparing to administer BioThrax to a group of enlisted soldiers who are going to be deployed to an active combat area
The group of soldiers is receiving the first of a series of the anthrax vaccine, and the nurse provides thorough education. What statement by a marine about the vaccine best demonstrates the need for further teaching? a. "I may experience muscle and joint aches." b. "I can expect my next vaccination in 2 weeks." c. "I can expect a scar from this vaccine." d. "I may experience a headache or feel fatigued."
Which of the following is a recommended guideline for applying a two-piece cervical collar on a patient?
A) Measure from the bottom of the chin to the top of the sternum, and measure around the neck. B) The left side of the collar should line up with the center of the patient's neck. C) Move the patient's head slightly to allow placement of the collar under the head. D) Be sure that the front half of the collar does not overlap the back half.
According to structural contingency theory, agencies should have more formal structures
1. When employees perform varying tasks 2. When employees have high levels of professional education 3. When the industry or environment in which the agency operates is changing 4. As the agency grows larger
The newest class of drugs for type 2 diabetes is called sodium-glucose co-transporter 2 (SGLT-2) inhibitors. What is an SGLT-2?
A. An enzyme in the small intestine responsible for breaking down complex carbohydrates into monosaccharides. B. A hormone secreted by the mucosa of the small intestine following a meal. C. An enzyme in the kidney tubule that causes glucose to be reasorbed from the urine